Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Nils Bergenhem is Director, Strategy & External Innovation for CVMD IMED Biotech Unit at AstraZeneca, and Alliance Coordinator for the CVMD portfolio in the AstraZeneca – Moderna mRNA collaboration. Prior to joining AstraZeneca, Nils was Chief Scientific Officer or VP Research at several US biotech and start-up companies focused on various aspects of metabolic diseases. Earlier in his career, Nils held positions of increasing importance at Novo Nordisk in Copenhagen. Nils holds an undergraduate degree in Chemistry from Linkoping University, Sweden, a Ph.D. in Biochemistry from Umeå University, Sweden, and has completed postdoctoral work at University of Michigan in Molecular Biology and Human Genetics.